Abstract: A coated implantable medical device is described, wherein the coating comprises a coating matrix and particles of one or more molecular sieves, preferably zeolite of zeogrid particles, optionally loaded with one or more bioactive agents. The coating matrix itself can function as a second drug-carrying interface. The coating comprising the molecular sieve material has an excellent biocompatibility and allows suitable drug delivery into the body of an animal, preferably a mammal and most preferably a human.

Abstract: The invention provides a controlled release delivery system comprising a bio-active compound and a matrix carrier, wherein said matrix carrier is an amorphous microporous non-fibrous silicon or titanium oxide being loaded with said bio-active compound and wherein the micropores of said matrix carrier have a mean size in the range of 0.4 to 2.0 nm.

Abstract: A hydrocracking catalyst containing at least one matrix, at least one zeolite chosen from the group formed by the zeolites ZBM-30, ZSM-48, EU-2, and EU-11, at least one Y zeolite, at least one hydro-dehydrogenating metal chosen from the group formed by the metals from Group VIB and Group VIII of the periodic table, optionally at least one element chosen from the group formed by phosphorus, boron and silicon, optionally at least one element from Group VIIA, and optionally at least one element from Group VIIB is used in a process of hydrocracking/hydroconversion of hydrocarbon charges.

Abstract: A catheter assembly with an ergonomic needle grip attached to a needle hub having an outer surface, a distal end, and a proximal end comprises a grip plate attached to and extending radially from the outer surface of the needle hub. The grip plate forms an obtuse angle with an axis extending longitudinally along a centerline of a needle, wherein the angle is measured from a point on the axis near the proximal end of the needle hub. A flashback chamber of the catheter assembly located near the proximal end of the needle hub is visible when a digit is placed on the grip plate.

Abstract: A catalyst comprising at least one ZBM-30 zeolite, synthesized in the presence of a particular structuring agent such as triethylenetetramine, at least one porous mineral matrix, at least one hydro-dehydrogenating element, preferably chosen from the elements of Group VIB and Group VIII of the periodic table, is used in order to improve the pour point of charges containing long (more than 10 carbon atoms) linear and/or slightly branched paraffins, in particular in order to convert, with a good yield, charges having high pour points to at least one cut having a low pour point and a high viscosity index for oil bases.

Abstract: The invention provides a method for reducing the average size of biologically active compound particles or agglomerates suspended in a fluid by flowing one or more times said fluid having biologically active compound particles or agglomerates suspended therein through one or more magnetic fields to reduce the average size of a substantial portion of the biologically active compound particles or agglomerates by at least 25%. This method may be incorporated into a process for manufacturing a 10 biologically active compound formulation.

Abstract: The invention concerns a process for the synthesis of solid zeolitic ZBM-30, comprising: i) a mixing step, during which a mixture comprising at least one source of a tetravalent metal, at least one source of a trivalent metal, water and at least two amine compounds is prepared, resulting in the production of a gel; and ii) a crystallization step, during which said gel is maintained under conditions allowing the formation of a crystalline solid. The invention also concerns the zeolite ZBM-30 obtained by said process.

Abstract: A process for oligomerising alkenes having from 3 to 6 carbon atoms which comprises contacting a feedstock comprising a) one or several alkenes having x carbon atoms, and, b) optionally, one or several alkenes having y carbon atoms, x and y being different, with a catalyst containing a zeolite of the MFS structure type, under conditions to obtain selectively oligomeric product containing predominant amounts of certain oligomers. The process is carried out at a temperature comprised between 125 and 175° C. when the feedstock contains only alkenes with 3 carbon atoms and between 140 and 240° C., preferably between 140 and 200° C. when the feedstock contains comprises at least one alkene with 4 or more carbon atoms.

Abstract: The invention concerns a solid crystalline designated COK-7, which has a particular X ray diffraction diagram. Said solid has a chemical composition, expressed on an anhydrous base in terms of moles of oxides by the formula XO2: mYO2, X representing one or more tetravalent element(s), Y representing at least one trivalent element. The invention also concerns a process for preparing said solid and the use of said solid in hydrocarbon transformation.

Abstract: The invention describes a new class of crystalline silica material having two levels or porosity and structural order. At the first level, building units are nanoslabs of uniform size having zeolite framework. At the second structural level, nanoslabs are assembled, e.g. linked through their corners, edges or faces following patterns imposed by interaction with cationic surfactant or triblock copolymer molecules. After evacuation of these molecules, microporosity is obtained inside the nanoslabs, and a precise mesoporosity between the nanoslabs depending on the tiling pattern of the zeolite nanoslabs, as evidenced by X-ray diffraction. These materials are useful for the fixation of biologically active species, such as poorly soluble drugs.

Abstract: The invention relates to a method and a system for the emulsification of a pre-mix of two or more immiscible liquids by flowing or circulating one or more times said pre-mix through one or more magnetic fields.

Abstract: The invention relates to an intraluminal device, in particular an intraluminal prosthesis, shunt, catheter or local drug delivery device, provided with at least one coating containing a therapeutic agent comprised in a matrix which sticks to the intraluminal device, characterised in that said matrix is formed by a biocompatible oil or fat, which oil or fat is a chemically hardened oil or fat.

Abstract: The invention pertains to a catalyst that consists of a substrate made of at least one matrix and at least one zeolite that is selected from the group composed of the zeolites ZSM-48, EU-11, and ZBM-30, whereby, at the level of the zeolite, at least one noble metal of Group VIII is deposited on said substrate. The noble metal is preferably located on the outer surfaces of the zeolite crystals, and more preferable at the mouths of pores. The invention also pertains to a process for preparing the catalyst and utilizing the catalyst to treat hydrocarbon feedstocks, and especially for improving their pour points.

Abstract: The invention relates to an intraluminal device, in particular an intraluminal prosthesis, shunt, catheter or local drug delivery device. In order to increase the bio-compatibility of this device, it is provided with at least one coating. The coating contains a therapeutic agent which is comprised in a matrix that sticks to the intraluminal device. Instead of being formed by a little bio-compatible polymer, the matrix is formed by a bio-compatible oil or fat, such as cod-liver oil or olive oil. Preferably, the bio-compatible oil or fat further comprises alfa-tocopherol.

Abstract: Method and apparatus for reducing the average size of metallic compound particles or agglomerates suspended in a fluid by flowing one or more times said fluid having metallic compound particles or agglomerates suspended therein through one or more magnetic fields to reduce the average size of a substantial portion of the metallic compound particles or agglomerates by at least 25%.

Abstract: A catalyst comprising at least one zeolite (molecular sieve) chosen from the group formed by the TON structure type zeolites (Theta-1, ZSM-22, ISI-1, NU-10 and KZ-2) and at least one zeolite chosen from the group formed by the zeolites (ZSM-48, EU-2, EU-11 and ZBM-30), at least one porous mineral matrix, at least one hydro-dehydrogenating element, preferably chosen from the elements of Group VIB and Group VIII of the periodic table, is used for the conversion of hydrocarbons, in particular for the reduction of the pour point of charges containing long (more than 10 carbon atoms) linear and/or slightly branched paraffins, in particular in order to convert, with a good yield, charges having high pour points to at least one cut having a low pour point and a high viscosity index for oil bases.

Abstract: Porous material (1) for catalytic conversion of exhaust gases including a carrier with a first porous structure (2, 2?), and an oxidation catalyst (OX) which in the presence of oxygen (O2), according to a first reaction (3), has the ability to catalyze oxidation of nitrogen monoxide (NO) into nitrogen dioxide (NO2) and, according to a second reaction (4, 4?), to catalyze oxidation of a reducing agent (HC), which oxidation catalyst (OX) is enclosed inside the first porous structure (2, 2?). The invention is characterized in that the oxidation catalyst (OX) includes iron (Fe) and silver (Ag) loaded on a zeolite. The invention also relates to a method and an arrangement and a catalytic conversion device that utilizes the porous material, and indicates an advantageous use of the porous material.

Abstract: A catalyst comprising at least one ZBM-30 zeolite, synthesized in the presence of a particular structuring agent such as triethylenetetramine, at least one porous mineral matrix, at least one hydro-dehydrogenating element, preferably chosen from the elements of Group VIB and Group VIII of the periodic table, is used in order to improve the pour point of charges containing long (more than 10 carbon atoms) linear and/or slightly branched paraffins, in particular in order to convert, with a good yield, charges having high pour points to at least one cut having a low pour point and a high viscosity index for oil bases.

Abstract: A hydrocracking catalyst containing at least one matrix, at least one zeolite chosen from the group formed by the zeolites ZBM-30, ZSM-48, EU-2, and EU-11, at least one Y zeolite, at least one hydro-dehydrogenating metal chosen from the group formed by the metals from Group VIB and Group VIII of the periodic table, optionally at least one element chosen from the group formed by phosphorus, boron and silicon, optionally at least one element from Group VIIA, and optionally at least one element from Group VIIB is used in a process of hydrocracking/hydroconversion of hydrocarbon charges.

Abstract: A system and method for facilitating the routing of small information packages between nodes in a network. In particular, the system and method of the present invention utilize a routing table at each node of the network. The routing table for each node contains a list of the nodes, ordered the same in each table, and an indexing value is utilized to refer to particular node values. Internodal linkage information is also stored in the routing table along with an alternative link should the primary link fail. The addition/deletion of nodes and the failure of any link is handled by an update function.